SHELIA TREW: Open Payments
NPI 1578546990 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,432 in 122 payments from 16 companies in 2025. Trend: 2023 $2,215 · 2024 $2,871 · 2025 $2,432
Food & beverage: $2,348Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $711 |
| Janssen Biotech, Inc. | 21 | $478 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $257 |
| Aimmune Therapeutics, Inc. | 10 | $224 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $165 |
| Madrigal Pharmaceuticals | 5 | $119 |
| PFIZER INC. | 6 | $116 |
| Gilead Sciences, Inc. | 5 | $111 |
| Ardelyx, Inc. | 3 | $79 |
| Phathom Pharmaceuticals, Inc. | 4 | $54 |
Products named: TREMFYA, RINVOQ, XIFAXAN, SKYRIZI, ZENPEP, ENTYVIO, REZDIFFRA, XELJANZ.
Industry payments across TN — which companies pay providers there.
